India’s approval of own COVID vaccine criticised for lack of data
2021-01-04 08:27:55 source：The Aljazeera
January 3, 2021
India on Sunday granted emergency approval to Bharat Biotech’s Covaxin but faced questions after taking the step without publishing efficacy data for the homegrown coronavirus vaccine.
The news, announced by the drugs controller general of India (DCGI) who did not take questions, was hailed by Prime Minister Narendra Modi and his ministers as a success in India’s self-reliance push.
The government also approved the use of a vaccine developed by AstraZeneca and Oxford University which will be the lead vaccine in India’s immunisation programme until other shots are approved.
Read more:
https://www.aljazeera.com/news/2021/1/3/indias-approval-of-own-covid-vaccine-criticised-for-lack-of-data